902836-56-0

Upstream product

• 1035261-83-6 4-(3-(trifluoromethyl)phenyl)-tetrahydro-2H-pyran-4-carbonitrile 
• 141-78-6 ethyl acetate 
• 2338-76-3 3-trifluoromethylphenylacetonitrile 

Downstream Products

• 1356465-39-8 ethyl 3-(4-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-4-yl)propanoate 
• 1356465-41-2 tert-butyl 1-(4-(5-(2-(4-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-4-yl)ethyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate 
• 1356465-34-3 1-(4-(5-(2-(4-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-4-yl)ethyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid 
• 1356465-38-7 3-(4-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-4-yl)propanoic acid 
• 1356465-37-6 ethyl 3-(4-(3-(trifluoromethyl)phenyl)tetrahydro-2H-pyran-4-yl)acrylate 

Relevant academic research and scientific papers

SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS

Disclosed are compounds of Formula (I): [PLEASE INSERT CHEMICAL STRUCTURE HERE] or stereoisomers, N-oxides, salts, or prodrugs thereof; wherein: Ring A is phenyl or 5- to 6-membered heteroaryl; (i) R1 and R2 are independently C1-C4 alkyl; or (ii) R1 and R

SUBSTITUTED 3-PHENYL-1,2,4-OXADIAZOLE COMPOUNDS

Disclosed are compounds of Formula (I): (I) or stereoisomers, salts, or prodrugs thereof, wherein: (i) R1 and R2 are independently C1-C4 alkyl, or (ii) R1 and R2 together with the carbon atom to which they are a